Selected research
Industry Research
Proteomics Analytical Service Industry Research Report 2026
Market perspective
The global Proteomics Analytical Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Proteomics Analytical Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Proteomics Analytical Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Proteomics Analytical Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Proteomics Analytical Service include PTM BIO, Standard Biotools, Labcorp, BostonGene, APTBIO, Cell Signaling Technology (CST), Inotiv, Bruker Spatial Biology and BGI Genomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Proteomics Analytical Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Proteomics Analytical Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Proteomics Analytical Service Market by Company
PTM BIO
Standard Biotools
Labcorp
BostonGene
APTBIO
Cell Signaling Technology (CST)
Inotiv
Bruker Spatial Biology
BGI Genomics
Biognosys
Crown Bioscience
Eurofins Scientific
Charles River Laboratories
Discovery Life Sciences
Shanghai OE Biotech
Biodesix
Novogene
OmicScouts (Momentum Biotechnologies)
Lc-Bio Technologies
Creative Proteomics
Metware Biotechnology
GENEWIZ (Azenta Life Sciences)
CDI Labs
Evotec
MS Bioworks
Shanghai Bioprofile
MtoZ-Biolabs
Shanghai Majorbio Bio-Pharm
Firalis Molecular Precision
CD Genomics
MRM Proteomics
Panome Bio
Beijing Biomarker Technologies
Sampled (Infinity Biologix)
Sinotech Genomics
Applied Biomics
Westlake Omics
Sapient Bioanalytics
RxCelerate
Vizgen
Allumiqs
VProteomics
Precision Biomarker Laboratories (PBL)
Proteome Sciences
Proteomics International
TATAA Biocenter
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
CellCarta
Proteomics Analytical Service Segment by Type
Standard Proteomics
Modified Proteomics
Spatial Proteomics
Blood Proteomics
Other Proteomics
Proteomics Analytical Service Segment by Application
Clinical Diagnostics
Drug Discovery
Others
Proteomics Analytical Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proteomics Analytical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Proteomics Analytical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proteomics Analytical Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Proteomics Analytical Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Standard Proteomics
- Modified Proteomics
- Spatial Proteomics
- Blood Proteomics
- Other Proteomics
Applications
- Clinical Diagnostics
- Drug Discovery
- Others
Companies covered
- PTM BIO
- Standard Biotools
- Labcorp
- BostonGene
- APTBIO
- Cell Signaling Technology (CST)
- Inotiv
- Bruker Spatial Biology
- BGI Genomics
- Biognosys
- Crown Bioscience
- Eurofins Scientific
- Charles River Laboratories
- Discovery Life Sciences
- Shanghai OE Biotech
- Biodesix
- Novogene
- OmicScouts (Momentum Biotechnologies)
- Lc-Bio Technologies
- Creative Proteomics
- Metware Biotechnology
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Evotec
- MS Bioworks
- Shanghai Bioprofile
- MtoZ-Biolabs
- Shanghai Majorbio Bio-Pharm
- Firalis Molecular Precision
- CD Genomics
- MRM Proteomics
- Panome Bio
- Beijing Biomarker Technologies
- Sampled (Infinity Biologix)
- Sinotech Genomics
- Applied Biomics
- Westlake Omics
- Sapient Bioanalytics
- RxCelerate
- Vizgen
- Allumiqs
- VProteomics
- Precision Biomarker Laboratories (PBL)
- Proteome Sciences
- Proteomics International
- TATAA Biocenter
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- CellCarta
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Proteomics Analytical Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Standard Proteomics
- 2.2.3 Modified Proteomics
- 2.2.4 Spatial Proteomics
- 2.2.5 Blood Proteomics
- 2.2.6 Other Proteomics
- 2.3 Proteomics Analytical Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnostics
- 2.3.3 Drug Discovery
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Proteomics Analytical Service Breakdown Data by Type
- 3.1 Global Proteomics Analytical Service Historic Market Size by Type (2021-2026)
- 3.2 Global Proteomics Analytical Service Forecasted Market Size by Type (2027-2032)
4 Proteomics Analytical Service Breakdown Data by Application
- 4.1 Global Proteomics Analytical Service Historic Market Size by Application (2021-2026)
- 4.2 Global Proteomics Analytical Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Proteomics Analytical Service Market Perspective (2021-2032)
- 5.2 Global Proteomics Analytical Service Growth Trends by Region
- 5.2.1 Global Proteomics Analytical Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Proteomics Analytical Service Historic Market Size by Region (2021-2026)
- 5.2.3 Proteomics Analytical Service Forecasted Market Size by Region (2027-2032)
- 5.3 Proteomics Analytical Service Market Dynamics
- 5.3.1 Proteomics Analytical Service Industry Trends
- 5.3.2 Proteomics Analytical Service Market Drivers
- 5.3.3 Proteomics Analytical Service Market Challenges
- 5.3.4 Proteomics Analytical Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Proteomics Analytical Service Players by Revenue
- 6.1.1 Global Top Proteomics Analytical Service Players by Revenue (2021-2026)
- 6.1.2 Global Proteomics Analytical Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Proteomics Analytical Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Proteomics Analytical Service Head Office and Area Served
- 6.4 Global Proteomics Analytical Service Players, Product Type & Application
- 6.5 Global Proteomics Analytical Service Manufacturers Established Date
- 6.6 Global Proteomics Analytical Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Proteomics Analytical Service Market Size (2021-2032)
- 7.2 North America Proteomics Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Proteomics Analytical Service Market Size by Country (2021-2026)
- 7.4 North America Proteomics Analytical Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Proteomics Analytical Service Market Size (2021-2032)
- 8.2 Europe Proteomics Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Proteomics Analytical Service Market Size by Country (2021-2026)
- 8.4 Europe Proteomics Analytical Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Proteomics Analytical Service Market Size (2021-2032)
- 9.2 Asia-Pacific Proteomics Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Proteomics Analytical Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Proteomics Analytical Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Proteomics Analytical Service Market Size (2021-2032)
- 10.2 South America Proteomics Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Proteomics Analytical Service Market Size by Country (2021-2026)
- 10.4 South America Proteomics Analytical Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Proteomics Analytical Service Market Size (2021-2032)
- 11.2 Middle East & Africa Proteomics Analytical Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Proteomics Analytical Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Proteomics Analytical Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PTM BIO
- 12.1.1 PTM BIO Company Information
- 12.1.2 PTM BIO Business Overview
- 12.1.3 PTM BIO Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.1.4 PTM BIO Proteomics Analytical Service Product Portfolio
- 12.1.5 PTM BIO Recent Developments
- 12.2 Standard Biotools
- 12.2.1 Standard Biotools Company Information
- 12.2.2 Standard Biotools Business Overview
- 12.2.3 Standard Biotools Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.2.4 Standard Biotools Proteomics Analytical Service Product Portfolio
- 12.2.5 Standard Biotools Recent Developments
- 12.3 Labcorp
- 12.3.1 Labcorp Company Information
- 12.3.2 Labcorp Business Overview
- 12.3.3 Labcorp Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.3.4 Labcorp Proteomics Analytical Service Product Portfolio
- 12.3.5 Labcorp Recent Developments
- 12.4 BostonGene
- 12.4.1 BostonGene Company Information
- 12.4.2 BostonGene Business Overview
- 12.4.3 BostonGene Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.4.4 BostonGene Proteomics Analytical Service Product Portfolio
- 12.4.5 BostonGene Recent Developments
- 12.5 APTBIO
- 12.5.1 APTBIO Company Information
- 12.5.2 APTBIO Business Overview
- 12.5.3 APTBIO Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.5.4 APTBIO Proteomics Analytical Service Product Portfolio
- 12.5.5 APTBIO Recent Developments
- 12.6 Cell Signaling Technology (CST)
- 12.6.1 Cell Signaling Technology (CST) Company Information
- 12.6.2 Cell Signaling Technology (CST) Business Overview
- 12.6.3 Cell Signaling Technology (CST) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.6.4 Cell Signaling Technology (CST) Proteomics Analytical Service Product Portfolio
- 12.6.5 Cell Signaling Technology (CST) Recent Developments
- 12.7 Inotiv
- 12.7.1 Inotiv Company Information
- 12.7.2 Inotiv Business Overview
- 12.7.3 Inotiv Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.7.4 Inotiv Proteomics Analytical Service Product Portfolio
- 12.7.5 Inotiv Recent Developments
- 12.8 Bruker Spatial Biology
- 12.8.1 Bruker Spatial Biology Company Information
- 12.8.2 Bruker Spatial Biology Business Overview
- 12.8.3 Bruker Spatial Biology Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.8.4 Bruker Spatial Biology Proteomics Analytical Service Product Portfolio
- 12.8.5 Bruker Spatial Biology Recent Developments
- 12.9 BGI Genomics
- 12.9.1 BGI Genomics Company Information
- 12.9.2 BGI Genomics Business Overview
- 12.9.3 BGI Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.9.4 BGI Genomics Proteomics Analytical Service Product Portfolio
- 12.9.5 BGI Genomics Recent Developments
- 12.10 Biognosys
- 12.10.1 Biognosys Company Information
- 12.10.2 Biognosys Business Overview
- 12.10.3 Biognosys Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.10.4 Biognosys Proteomics Analytical Service Product Portfolio
- 12.10.5 Biognosys Recent Developments
- 12.11 Crown Bioscience
- 12.11.1 Crown Bioscience Company Information
- 12.11.2 Crown Bioscience Business Overview
- 12.11.3 Crown Bioscience Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.11.4 Crown Bioscience Proteomics Analytical Service Product Portfolio
- 12.11.5 Crown Bioscience Recent Developments
- 12.12 Eurofins Scientific
- 12.12.1 Eurofins Scientific Company Information
- 12.12.2 Eurofins Scientific Business Overview
- 12.12.3 Eurofins Scientific Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.12.4 Eurofins Scientific Proteomics Analytical Service Product Portfolio
- 12.12.5 Eurofins Scientific Recent Developments
- 12.13 Charles River Laboratories
- 12.13.1 Charles River Laboratories Company Information
- 12.13.2 Charles River Laboratories Business Overview
- 12.13.3 Charles River Laboratories Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.13.4 Charles River Laboratories Proteomics Analytical Service Product Portfolio
- 12.13.5 Charles River Laboratories Recent Developments
- 12.14 Discovery Life Sciences
- 12.14.1 Discovery Life Sciences Company Information
- 12.14.2 Discovery Life Sciences Business Overview
- 12.14.3 Discovery Life Sciences Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.14.4 Discovery Life Sciences Proteomics Analytical Service Product Portfolio
- 12.14.5 Discovery Life Sciences Recent Developments
- 12.15 Shanghai OE Biotech
- 12.15.1 Shanghai OE Biotech Company Information
- 12.15.2 Shanghai OE Biotech Business Overview
- 12.15.3 Shanghai OE Biotech Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.15.4 Shanghai OE Biotech Proteomics Analytical Service Product Portfolio
- 12.15.5 Shanghai OE Biotech Recent Developments
- 12.16 Biodesix
- 12.16.1 Biodesix Company Information
- 12.16.2 Biodesix Business Overview
- 12.16.3 Biodesix Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.16.4 Biodesix Proteomics Analytical Service Product Portfolio
- 12.16.5 Biodesix Recent Developments
- 12.17 Novogene
- 12.17.1 Novogene Company Information
- 12.17.2 Novogene Business Overview
- 12.17.3 Novogene Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.17.4 Novogene Proteomics Analytical Service Product Portfolio
- 12.17.5 Novogene Recent Developments
- 12.18 OmicScouts (Momentum Biotechnologies)
- 12.18.1 OmicScouts (Momentum Biotechnologies) Company Information
- 12.18.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 12.18.3 OmicScouts (Momentum Biotechnologies) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.18.4 OmicScouts (Momentum Biotechnologies) Proteomics Analytical Service Product Portfolio
- 12.18.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 12.19 Lc-Bio Technologies
- 12.19.1 Lc-Bio Technologies Company Information
- 12.19.2 Lc-Bio Technologies Business Overview
- 12.19.3 Lc-Bio Technologies Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.19.4 Lc-Bio Technologies Proteomics Analytical Service Product Portfolio
- 12.19.5 Lc-Bio Technologies Recent Developments
- 12.20 Creative Proteomics
- 12.20.1 Creative Proteomics Company Information
- 12.20.2 Creative Proteomics Business Overview
- 12.20.3 Creative Proteomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.20.4 Creative Proteomics Proteomics Analytical Service Product Portfolio
- 12.20.5 Creative Proteomics Recent Developments
- 12.21 Metware Biotechnology
- 12.21.1 Metware Biotechnology Company Information
- 12.21.2 Metware Biotechnology Business Overview
- 12.21.3 Metware Biotechnology Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.21.4 Metware Biotechnology Proteomics Analytical Service Product Portfolio
- 12.21.5 Metware Biotechnology Recent Developments
- 12.22 GENEWIZ (Azenta Life Sciences)
- 12.22.1 GENEWIZ (Azenta Life Sciences) Company Information
- 12.22.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 12.22.3 GENEWIZ (Azenta Life Sciences) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.22.4 GENEWIZ (Azenta Life Sciences) Proteomics Analytical Service Product Portfolio
- 12.22.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 12.23 CDI Labs
- 12.23.1 CDI Labs Company Information
- 12.23.2 CDI Labs Business Overview
- 12.23.3 CDI Labs Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.23.4 CDI Labs Proteomics Analytical Service Product Portfolio
- 12.23.5 CDI Labs Recent Developments
- 12.24 Evotec
- 12.24.1 Evotec Company Information
- 12.24.2 Evotec Business Overview
- 12.24.3 Evotec Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.24.4 Evotec Proteomics Analytical Service Product Portfolio
- 12.24.5 Evotec Recent Developments
- 12.25 MS Bioworks
- 12.25.1 MS Bioworks Company Information
- 12.25.2 MS Bioworks Business Overview
- 12.25.3 MS Bioworks Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.25.4 MS Bioworks Proteomics Analytical Service Product Portfolio
- 12.25.5 MS Bioworks Recent Developments
- 12.26 Shanghai Bioprofile
- 12.26.1 Shanghai Bioprofile Company Information
- 12.26.2 Shanghai Bioprofile Business Overview
- 12.26.3 Shanghai Bioprofile Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.26.4 Shanghai Bioprofile Proteomics Analytical Service Product Portfolio
- 12.26.5 Shanghai Bioprofile Recent Developments
- 12.27 MtoZ-Biolabs
- 12.27.1 MtoZ-Biolabs Company Information
- 12.27.2 MtoZ-Biolabs Business Overview
- 12.27.3 MtoZ-Biolabs Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.27.4 MtoZ-Biolabs Proteomics Analytical Service Product Portfolio
- 12.27.5 MtoZ-Biolabs Recent Developments
- 12.28 Shanghai Majorbio Bio-Pharm
- 12.28.1 Shanghai Majorbio Bio-Pharm Company Information
- 12.28.2 Shanghai Majorbio Bio-Pharm Business Overview
- 12.28.3 Shanghai Majorbio Bio-Pharm Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.28.4 Shanghai Majorbio Bio-Pharm Proteomics Analytical Service Product Portfolio
- 12.28.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 12.29 Firalis Molecular Precision
- 12.29.1 Firalis Molecular Precision Company Information
- 12.29.2 Firalis Molecular Precision Business Overview
- 12.29.3 Firalis Molecular Precision Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.29.4 Firalis Molecular Precision Proteomics Analytical Service Product Portfolio
- 12.29.5 Firalis Molecular Precision Recent Developments
- 12.30 CD Genomics
- 12.30.1 CD Genomics Company Information
- 12.30.2 CD Genomics Business Overview
- 12.30.3 CD Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.30.4 CD Genomics Proteomics Analytical Service Product Portfolio
- 12.30.5 CD Genomics Recent Developments
- 12.31 MRM Proteomics
- 12.31.1 MRM Proteomics Company Information
- 12.31.2 MRM Proteomics Business Overview
- 12.31.3 MRM Proteomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.31.4 MRM Proteomics Proteomics Analytical Service Product Portfolio
- 12.31.5 MRM Proteomics Recent Developments
- 12.32 Panome Bio
- 12.32.1 Panome Bio Company Information
- 12.32.2 Panome Bio Business Overview
- 12.32.3 Panome Bio Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.32.4 Panome Bio Proteomics Analytical Service Product Portfolio
- 12.32.5 Panome Bio Recent Developments
- 12.33 Beijing Biomarker Technologies
- 12.33.1 Beijing Biomarker Technologies Company Information
- 12.33.2 Beijing Biomarker Technologies Business Overview
- 12.33.3 Beijing Biomarker Technologies Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.33.4 Beijing Biomarker Technologies Proteomics Analytical Service Product Portfolio
- 12.33.5 Beijing Biomarker Technologies Recent Developments
- 12.34 Sampled (Infinity Biologix)
- 12.34.1 Sampled (Infinity Biologix) Company Information
- 12.34.2 Sampled (Infinity Biologix) Business Overview
- 12.34.3 Sampled (Infinity Biologix) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.34.4 Sampled (Infinity Biologix) Proteomics Analytical Service Product Portfolio
- 12.34.5 Sampled (Infinity Biologix) Recent Developments
- 12.35 Sinotech Genomics
- 12.35.1 Sinotech Genomics Company Information
- 12.35.2 Sinotech Genomics Business Overview
- 12.35.3 Sinotech Genomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.35.4 Sinotech Genomics Proteomics Analytical Service Product Portfolio
- 12.35.5 Sinotech Genomics Recent Developments
- 12.36 Applied Biomics
- 12.36.1 Applied Biomics Company Information
- 12.36.2 Applied Biomics Business Overview
- 12.36.3 Applied Biomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.36.4 Applied Biomics Proteomics Analytical Service Product Portfolio
- 12.36.5 Applied Biomics Recent Developments
- 12.37 Westlake Omics
- 12.37.1 Westlake Omics Company Information
- 12.37.2 Westlake Omics Business Overview
- 12.37.3 Westlake Omics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.37.4 Westlake Omics Proteomics Analytical Service Product Portfolio
- 12.37.5 Westlake Omics Recent Developments
- 12.38 Sapient Bioanalytics
- 12.38.1 Sapient Bioanalytics Company Information
- 12.38.2 Sapient Bioanalytics Business Overview
- 12.38.3 Sapient Bioanalytics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.38.4 Sapient Bioanalytics Proteomics Analytical Service Product Portfolio
- 12.38.5 Sapient Bioanalytics Recent Developments
- 12.39 RxCelerate
- 12.39.1 RxCelerate Company Information
- 12.39.2 RxCelerate Business Overview
- 12.39.3 RxCelerate Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.39.4 RxCelerate Proteomics Analytical Service Product Portfolio
- 12.39.5 RxCelerate Recent Developments
- 12.40 Vizgen
- 12.40.1 Vizgen Company Information
- 12.40.2 Vizgen Business Overview
- 12.40.3 Vizgen Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.40.4 Vizgen Proteomics Analytical Service Product Portfolio
- 12.40.5 Vizgen Recent Developments
- 12.41 Allumiqs
- 12.41.1 Allumiqs Company Information
- 12.41.2 Allumiqs Business Overview
- 12.41.3 Allumiqs Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.41.4 Allumiqs Proteomics Analytical Service Product Portfolio
- 12.41.5 Allumiqs Recent Developments
- 12.42 VProteomics
- 12.42.1 VProteomics Company Information
- 12.42.2 VProteomics Business Overview
- 12.42.3 VProteomics Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.42.4 VProteomics Proteomics Analytical Service Product Portfolio
- 12.42.5 VProteomics Recent Developments
- 12.43 Precision Biomarker Laboratories (PBL)
- 12.43.1 Precision Biomarker Laboratories (PBL) Company Information
- 12.43.2 Precision Biomarker Laboratories (PBL) Business Overview
- 12.43.3 Precision Biomarker Laboratories (PBL) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.43.4 Precision Biomarker Laboratories (PBL) Proteomics Analytical Service Product Portfolio
- 12.43.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 12.44 Proteome Sciences
- 12.44.1 Proteome Sciences Company Information
- 12.44.2 Proteome Sciences Business Overview
- 12.44.3 Proteome Sciences Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.44.4 Proteome Sciences Proteomics Analytical Service Product Portfolio
- 12.44.5 Proteome Sciences Recent Developments
- 12.45 Proteomics International
- 12.45.1 Proteomics International Company Information
- 12.45.2 Proteomics International Business Overview
- 12.45.3 Proteomics International Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.45.4 Proteomics International Proteomics Analytical Service Product Portfolio
- 12.45.5 Proteomics International Recent Developments
- 12.46 TATAA Biocenter
- 12.46.1 TATAA Biocenter Company Information
- 12.46.2 TATAA Biocenter Business Overview
- 12.46.3 TATAA Biocenter Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.46.4 TATAA Biocenter Proteomics Analytical Service Product Portfolio
- 12.46.5 TATAA Biocenter Recent Developments
- 12.47 Cosmos Wisdom
- 12.47.1 Cosmos Wisdom Company Information
- 12.47.2 Cosmos Wisdom Business Overview
- 12.47.3 Cosmos Wisdom Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.47.4 Cosmos Wisdom Proteomics Analytical Service Product Portfolio
- 12.47.5 Cosmos Wisdom Recent Developments
- 12.48 Olink (Thermo Fisher Scientific)
- 12.48.1 Olink (Thermo Fisher Scientific) Company Information
- 12.48.2 Olink (Thermo Fisher Scientific) Business Overview
- 12.48.3 Olink (Thermo Fisher Scientific) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.48.4 Olink (Thermo Fisher Scientific) Proteomics Analytical Service Product Portfolio
- 12.48.5 Olink (Thermo Fisher Scientific) Recent Developments
- 12.49 SomaLogic (Illumina)
- 12.49.1 SomaLogic (Illumina) Company Information
- 12.49.2 SomaLogic (Illumina) Business Overview
- 12.49.3 SomaLogic (Illumina) Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.49.4 SomaLogic (Illumina) Proteomics Analytical Service Product Portfolio
- 12.49.5 SomaLogic (Illumina) Recent Developments
- 12.50 CellCarta
- 12.50.1 CellCarta Company Information
- 12.50.2 CellCarta Business Overview
- 12.50.3 CellCarta Revenue in Proteomics Analytical Service Business (2021-2026)
- 12.50.4 CellCarta Proteomics Analytical Service Product Portfolio
- 12.50.5 CellCarta Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst